These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7826135)

  • 1. Urine neopterin: a new parameter for serial monitoring of disease activity in patients with systemic lupus erythematosus.
    Lim KL; Muir K; Powell RJ
    Ann Rheum Dis; 1994 Nov; 53(11):743-8. PubMed ID: 7826135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urine neopterin as a parameter of disease activity in patients with systemic lupus erythematosus: comparisons with serum sIL-2R and antibodies to dsDNA, erythrocyte sedimentation rate, and plasma C3, C4, and C3 degradation products.
    Lim KL; Jones AC; Brown NS; Powell RJ
    Ann Rheum Dis; 1993 Jun; 52(6):429-35. PubMed ID: 8323394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary neopterin in patients with systemic lupus erythematosus.
    Leohirun L; Thuvasethakul P; Sumethkul V; Pholcharoen T; Boonpucknavig V
    Clin Chem; 1991 Jan; 37(1):47-50. PubMed ID: 1988207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of ESR, C3, C4, anti-DNA and lupus activity based on British Isles Lupus Assessment Group Index in patients of rheumatology clinic.
    Nasiri S; Karimifar M; Bonakdar ZS; Salesi M
    Rheumatol Int; 2010 Nov; 30(12):1605-9. PubMed ID: 19809816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A decrease in complement is associated with increased renal and hematologic activity in patients with systemic lupus erythematosus.
    Ho A; Barr SG; Magder LS; Petri M
    Arthritis Rheum; 2001 Oct; 44(10):2350-7. PubMed ID: 11665976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. British Isles Lupus Assessment Group 2004 index is valid for assessment of disease activity in systemic lupus erythematosus.
    Yee CS; Farewell V; Isenberg DA; Rahman A; Teh LS; Griffiths B; Bruce IN; Ahmad Y; Prabu A; Akil M; McHugh N; D'Cruz D; Khamashta MA; Maddison P; Gordon C
    Arthritis Rheum; 2007 Dec; 56(12):4113-9. PubMed ID: 18050213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of the prevalence and clinical associations of antibodies to human fibronectin in systemic lupus erythematosus.
    Atta MS; Lim KL; Ala'deen DA; Powell RJ; Todd I
    Ann Rheum Dis; 1995 Feb; 54(2):117-24. PubMed ID: 7702398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity and specificity of plasma and urine complement split products as indicators of lupus disease activity.
    Manzi S; Rairie JE; Carpenter AB; Kelly RH; Jagarlapudi SP; Sereika SM; Medsger TA; Ramsey-Goldman R
    Arthritis Rheum; 1996 Jul; 39(7):1178-88. PubMed ID: 8670328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum and urine interleukin-17A levels as biomarkers of disease activity in systemic lupus erythematosus.
    Nordin F; Shaharir SS; Abdul Wahab A; Mustafar R; Abdul Gafor AH; Mohamed Said MS; Rajalingham S; Shah SA
    Int J Rheum Dis; 2019 Aug; 22(8):1419-1426. PubMed ID: 31179646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subclinical disease activity in systemic lupus erythematosus: immunoinflammatory markers do not normalize in clinical remission.
    Wais T; Fierz W; Stoll T; Villiger PM
    J Rheumatol; 2003 Oct; 30(10):2133-9. PubMed ID: 14528506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoinflammatory markers and disease activity in systemic lupus erythematosus: something old, something new.
    Elwy MA; Galal ZA; Hasan HE
    East Mediterr Health J; 2010 Aug; 16(8):893-900. PubMed ID: 21469572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further validation of the BILAG disease activity index in patients with systemic lupus erythematosus.
    Stoll T; Stucki G; Malik J; Pyke S; Isenberg DA
    Ann Rheum Dis; 1996 Oct; 55(10):756-60. PubMed ID: 8984942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective analysis of C1 dissociation and complement activation in patients with systemic lupus erythematosus.
    Jonsson H; Sturfelt G; Mårtensson U; Truedsson L; Sjöholm AG
    Clin Exp Rheumatol; 1995; 13(5):573-80. PubMed ID: 8575134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
    Mahmoud RA; El-Gendi HI; Ahmed HH
    Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFNα and its response proteins, IP-10 and SIGLEC-1, are biomarkers of disease activity in systemic lupus erythematosus.
    Rose T; Grützkau A; Hirseland H; Huscher D; Dähnrich C; Dzionek A; Ozimkowski T; Schlumberger W; Enghard P; Radbruch A; Riemekasten G; Burmester GR; Hiepe F; Biesen R
    Ann Rheum Dis; 2013 Oct; 72(10):1639-45. PubMed ID: 23117242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baseline predictors of systemic lupus erythematosus flares: data from the combined placebo groups in the phase III belimumab trials.
    Petri MA; van Vollenhoven RF; Buyon J; Levy RA; Navarra SV; Cervera R; Zhong ZJ; Freimuth WW;
    Arthritis Rheum; 2013 Aug; 65(8):2143-53. PubMed ID: 23754628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neopterin and a soluble interleukin-2 receptor in patients with systemic lupus erythematodes].
    Horák P; Hermanová Z; Ordeltová M; Faltýnek L; Kusá L; Budíková M; Vavrdová V; Opíchalová D; Ciferská H; Scudla V
    Vnitr Lek; 2004 Jun; 50(6):422-7. PubMed ID: 15346634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum soluble markers of immune activation and disease activity in systemic lupus erythematosus.
    Samsonov MY; Tilz GP; Egorova O; Reibnegger G; Balabanova RM; Nassonov EL; Nassonova VA; Wachter H; Fuchs D
    Lupus; 1995 Feb; 4(1):29-32. PubMed ID: 7767335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urine β2-microglobulin is associated with clinical disease activity and renal involvement in female patients with systemic lupus erythematosus.
    Choe JY; Park SH; Kim SK
    Lupus; 2014 Dec; 23(14):1486-93. PubMed ID: 25124677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The influence of daily psychosocial stressors and associated emotions on the dynamic course of urine cortisol and urine neopterin in systemic lupus erythematosus: Experience taken from two "integrative single-case studies"].
    Christian S; Lampe A; Rumpold G; Geser W; Noisternig B; Chamson E; Schatz D; König P; Fuchs D; Schüssler G
    Z Psychosom Med Psychother; 2001; 47(1):58-79. PubMed ID: 11593454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.